F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Glucagon-like peptide-1

Page 1 of 1 ( 30 items )
<<
1
>>

1	Role of glucagon-like peptide-1 receptor agonists in pediatric obesity and metabolic dysfunction associated steatotic liver disease 6/16/2025 10:38:30 AM \| Browse: 86 \| Download: 481
2	Jejunoileal side-to-side anastomosis: New hope for patients with type 2 diabetes? 4/25/2025 7:53:53 AM \| Browse: 106 \| Download: 446
3	Metabolic improvement effects of jejunoileal side-to-side anastomosis in type 2 diabetes patients and the glucagon-like peptide-1 mechanism 2/28/2025 10:46:11 AM \| Browse: 169 \| Download: 569
4	Intestinal glucagon-like peptide-1: A new regulator of impaired counterregulatory responses to hypoglycemia in type 1 diabetes mellitus 11/30/2024 3:48:47 AM \| Browse: 171 \| Download: 737
5	Intestinal glucagon-like peptide-1 in hypoglycemic counterregulation for type 1 diabetes management 11/18/2024 3:30:36 AM \| Browse: 161 \| Download: 569
6	Surgical or medical treatment of obesity-associated type 2 diabetes-an increasing clinical conundrum 9/26/2024 8:51:03 AM \| Browse: 142 \| Download: 562
7	Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy? 8/27/2024 3:11:19 PM \| Browse: 145 \| Download: 722
8	Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy 8/22/2024 9:36:31 AM \| Browse: 131 \| Download: 580
9	Intestinal glucagon-like peptide-1: A new player associated with impaired counterregulatory responses to hypoglycaemia in type 1 diabetic mice 7/26/2024 6:56:10 AM \| Browse: 160 \| Download: 1096
10	Impacts of different pancreatic resection ranges on the endocrine function in Suncus murinus 7/22/2024 11:57:18 AM \| Browse: 180 \| Download: 770
11	Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease 6/21/2024 3:14:32 AM \| Browse: 182 \| Download: 639
12	Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges 5/22/2024 11:33:24 AM \| Browse: 124 \| Download: 569
13	Cardioprotective effects of glucagon-like peptide 1 receptor agonists in heart failure: Myth or truth? 5/10/2024 11:51:40 AM \| Browse: 230 \| Download: 686
14	Enhanced glucose homeostasis via Clostridium symbiosum-mediated glucagon-like peptide 1 inhibition of hepatic gluconeogenesis in mid-intestinal bypass surgery 10/19/2023 4:26:38 PM \| Browse: 286 \| Download: 1319
15	Hypothesis that alpha-amylase evokes regulatory mechanisms originating in the pancreas, gut and circulation, which govern glucose/insulin homeostasis 9/13/2023 12:15:07 PM \| Browse: 414 \| Download: 1190
16	Inter-relationships between gastric emptying and glycaemia: Implications for clinical practice 5/15/2023 3:23:22 PM \| Browse: 318 \| Download: 843
17	Correlation between gut microbiota and glucagon-like peptide-1 in patients with gestational diabetes mellitus 10/14/2022 8:30:45 AM \| Browse: 488 \| Download: 1925
18	Improved systemic half-life of glucagon-like peptide-1-loaded carbonate apatite nanoparticles in rats 8/12/2022 11:48:45 AM \| Browse: 646 \| Download: 1628
19	Significance of serum glucagon-like peptide-1 and matrix Gla protein levels in patients with diabetes and osteoporosis 2/11/2022 5:55:19 AM \| Browse: 656 \| Download: 1582
20	Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease 12/14/2021 5:28:58 AM \| Browse: 693 \| Download: 1695
21	Exercise and glucagon-like peptide-1: Does exercise potentiate the effect of treatment? 8/15/2018 7:53:03 AM \| Browse: 1149 \| Download: 2050
22	Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus 6/15/2018 3:55:56 AM \| Browse: 1291 \| Download: 2358
23	Pharmacological inhibition of diacylglycerol acyltransferase-1 and insights into postprandial gut peptide secretion 11/13/2017 1:14:28 AM \| Browse: 1319 \| Download: 2613
24	Effect of Roux-en-Y gastric bypass surgery on intestinal Akkermansia muciniphila 4/19/2016 5:23:00 PM \| Browse: 1214 \| Download: 2576
25	Osteocalcin as a hormone regulating glucose metabolism 12/21/2015 9:19:00 AM \| Browse: 1659 \| Download: 2771
26	Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide 6/20/2015 5:23:00 PM \| Browse: 1556 \| Download: 2417
27	Incretin-based therapies in prediabetes: Current evidence and future perspectives 12/13/2014 7:02:00 PM \| Browse: 1483 \| Download: 2213
28	Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats 9/1/2014 5:04:00 PM \| Browse: 1317 \| Download: 1744
29	Incretin based therapies: A novel treatment approach for non-alcoholic fatty liver disease 8/26/2014 2:46:00 PM \| Browse: 1158 \| Download: 1345
30	Potential roles of glucagon-like peptide-1-based therapies in treating non-alcoholic fatty liver disease 8/25/2014 5:12:00 PM \| Browse: 1165 \| Download: 1591

Page 1 of 1 ( 30 items )
<<
1
>>

1	Role of glucagon-like peptide-1 receptor agonists in pediatric obesity and metabolic dysfunction associated steatotic liver disease 6/16/2025 10:38:30 AM \| Browse: 86 \| Download: 481
2	Jejunoileal side-to-side anastomosis: New hope for patients with type 2 diabetes? 4/25/2025 7:53:53 AM \| Browse: 106 \| Download: 446
3	Metabolic improvement effects of jejunoileal side-to-side anastomosis in type 2 diabetes patients and the glucagon-like peptide-1 mechanism 2/28/2025 10:46:11 AM \| Browse: 169 \| Download: 569
4	Intestinal glucagon-like peptide-1: A new regulator of impaired counterregulatory responses to hypoglycemia in type 1 diabetes mellitus 11/30/2024 3:48:47 AM \| Browse: 171 \| Download: 737
5	Intestinal glucagon-like peptide-1 in hypoglycemic counterregulation for type 1 diabetes management 11/18/2024 3:30:36 AM \| Browse: 161 \| Download: 569
6	Surgical or medical treatment of obesity-associated type 2 diabetes-an increasing clinical conundrum 9/26/2024 8:51:03 AM \| Browse: 142 \| Download: 562
7	Macrophage modulation with dipeptidyl peptidase-4 inhibitors: A new frontier for treating diabetic cardiomyopathy? 8/27/2024 3:11:19 PM \| Browse: 145 \| Download: 722
8	Team players in the pathogenesis of metabolic dysfunctions-associated steatotic liver disease: The basis of development of pharmacotherapy 8/22/2024 9:36:31 AM \| Browse: 131 \| Download: 580
9	Intestinal glucagon-like peptide-1: A new player associated with impaired counterregulatory responses to hypoglycaemia in type 1 diabetic mice 7/26/2024 6:56:10 AM \| Browse: 160 \| Download: 1096
10	Impacts of different pancreatic resection ranges on the endocrine function in Suncus murinus 7/22/2024 11:57:18 AM \| Browse: 180 \| Download: 770
11	Role of gut-liver axis and glucagon-like peptide-1 receptor agonists in the treatment of metabolic dysfunction-associated fatty liver disease 6/21/2024 3:14:32 AM \| Browse: 182 \| Download: 639
12	Role of incretins and glucagon receptor agonists in metabolic dysfunction-associated steatotic liver disease: Opportunities and challenges 5/22/2024 11:33:24 AM \| Browse: 124 \| Download: 569
13	Cardioprotective effects of glucagon-like peptide 1 receptor agonists in heart failure: Myth or truth? 5/10/2024 11:51:40 AM \| Browse: 230 \| Download: 686
14	Enhanced glucose homeostasis via Clostridium symbiosum-mediated glucagon-like peptide 1 inhibition of hepatic gluconeogenesis in mid-intestinal bypass surgery 10/19/2023 4:26:38 PM \| Browse: 286 \| Download: 1319
15	Hypothesis that alpha-amylase evokes regulatory mechanisms originating in the pancreas, gut and circulation, which govern glucose/insulin homeostasis 9/13/2023 12:15:07 PM \| Browse: 414 \| Download: 1190
16	Inter-relationships between gastric emptying and glycaemia: Implications for clinical practice 5/15/2023 3:23:22 PM \| Browse: 318 \| Download: 843
17	Correlation between gut microbiota and glucagon-like peptide-1 in patients with gestational diabetes mellitus 10/14/2022 8:30:45 AM \| Browse: 488 \| Download: 1925
18	Improved systemic half-life of glucagon-like peptide-1-loaded carbonate apatite nanoparticles in rats 8/12/2022 11:48:45 AM \| Browse: 646 \| Download: 1628
19	Significance of serum glucagon-like peptide-1 and matrix Gla protein levels in patients with diabetes and osteoporosis 2/11/2022 5:55:19 AM \| Browse: 656 \| Download: 1582
20	Neuroprotection by dipeptidyl-peptidase-4 inhibitors and glucagon-like peptide-1 analogs via the modulation of AKT-signaling pathway in Alzheimer’s disease 12/14/2021 5:28:58 AM \| Browse: 693 \| Download: 1695
21	Exercise and glucagon-like peptide-1: Does exercise potentiate the effect of treatment? 8/15/2018 7:53:03 AM \| Browse: 1149 \| Download: 2050
22	Coagonist of glucagon-like peptide-1 and glucagon receptors ameliorates kidney injury in murine models of obesity and diabetes mellitus 6/15/2018 3:55:56 AM \| Browse: 1291 \| Download: 2358
23	Pharmacological inhibition of diacylglycerol acyltransferase-1 and insights into postprandial gut peptide secretion 11/13/2017 1:14:28 AM \| Browse: 1319 \| Download: 2613
24	Effect of Roux-en-Y gastric bypass surgery on intestinal Akkermansia muciniphila 4/19/2016 5:23:00 PM \| Browse: 1214 \| Download: 2576
25	Osteocalcin as a hormone regulating glucose metabolism 12/21/2015 9:19:00 AM \| Browse: 1659 \| Download: 2771
26	Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutide 6/20/2015 5:23:00 PM \| Browse: 1556 \| Download: 2417
27	Incretin-based therapies in prediabetes: Current evidence and future perspectives 12/13/2014 7:02:00 PM \| Browse: 1483 \| Download: 2213
28	Exenatide improves hepatic steatosis by enhancing lipid use in adipose tissue in nondiabetic rats 9/1/2014 5:04:00 PM \| Browse: 1317 \| Download: 1744
29	Incretin based therapies: A novel treatment approach for non-alcoholic fatty liver disease 8/26/2014 2:46:00 PM \| Browse: 1158 \| Download: 1345
30	Potential roles of glucagon-like peptide-1-based therapies in treating non-alcoholic fatty liver disease 8/25/2014 5:12:00 PM \| Browse: 1165 \| Download: 1591